Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Genomic aberrations of BRCA1-mutated fallopian tube carcinomas.

Hunter SM, Ryland GL, Moss P; kConFab Investigators, Gorringe KL, Campbell IG.

Am J Pathol. 2014 Jun;184(6):1871-6. doi: 10.1016/j.ajpath.2014.02.013. Epub 2014 Apr 13.

PMID:
24726640
2.

Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.

Morrison JC, Blanco LZ Jr, Vang R, Ronnett BM.

Am J Surg Pathol. 2015 Apr;39(4):442-53. doi: 10.1097/PAS.0000000000000352.

PMID:
25517955
3.
4.

Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.

Salvador S, Rempel A, Soslow RA, Gilks B, Huntsman D, Miller D.

Gynecol Oncol. 2008 Sep;110(3):408-17. doi: 10.1016/j.ygyno.2008.05.010. Epub 2008 Jul 1.

PMID:
18597838
5.

Serous tubal intraepithelial carcinoma in a Japanese woman with a deleterious BRCA1 mutation.

Ishikawa H, Kiyokawa T, Utsuno E, Matsushita K, Nomura F, Shozu M.

Jpn J Clin Oncol. 2014 Jun;44(6):597-601. doi: 10.1093/jjco/hyu035. Epub 2014 Apr 9.

PMID:
24719479
6.

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.

Cass I, Walts AE, Barbuto D, Lester J, Karlan B.

Gynecol Oncol. 2014 Sep;134(3):492-7. doi: 10.1016/j.ygyno.2014.07.084. Epub 2014 Jul 12.

PMID:
25026639
7.

Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.

Rabban JT, Krasik E, Chen LM, Powell CB, Crawford B, Zaloudek CJ.

Am J Surg Pathol. 2009 Dec;33(12):1878-85. doi: 10.1097/PAS.0b013e3181bc6059.

PMID:
19898224
8.

Are all pelvic (nonuterine) serous carcinomas of tubal origin?

Przybycin CG, Kurman RJ, Ronnett BM, Shih IeM, Vang R.

Am J Surg Pathol. 2010 Oct;34(10):1407-16. doi: 10.1097/PAS.0b013e3181ef7b16. Erratum in: Am J Surg Pathol. 2010 Dec;34(12):1891.

PMID:
20861711
9.

Wilms tumor gene immunoreactivity in primary serous carcinomas of the fallopian tube, ovary, endometrium, and peritoneum.

Hashi A, Yuminamochi T, Murata S, Iwamoto H, Honda T, Hoshi K.

Int J Gynecol Pathol. 2003 Oct;22(4):374-7.

PMID:
14501819
10.

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.

Olivier RI, van Beurden M, Lubsen MA, Rookus MA, Mooij TM, van de Vijver MJ, van't Veer LJ.

Br J Cancer. 2004 Apr 19;90(8):1492-7.

11.

Incidental nonuterine high-grade serous carcinomas arise in the fallopian tube in most cases: further evidence for the tubal origin of high-grade serous carcinomas.

Gilks CB, Irving J, Köbel M, Lee C, Singh N, Wilkinson N, McCluggage WG.

Am J Surg Pathol. 2015 Mar;39(3):357-64. doi: 10.1097/PAS.0000000000000353.

PMID:
25517954
13.

Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers.

Shaw PA, Rouzbahman M, Pizer ES, Pintilie M, Begley H.

Mod Pathol. 2009 Sep;22(9):1133-8. doi: 10.1038/modpathol.2009.89. Epub 2009 Jun 19.

14.

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

Crum CP, Drapkin R, Kindelberger D, Medeiros F, Miron A, Lee Y.

Clin Med Res. 2007 Mar;5(1):35-44. Review.

15.

Fallopian tube origin of supposed ovarian high-grade serous carcinomas.

Diniz PM, Carvalho JP, Baracat EC, Carvalho FM.

Clinics (Sao Paulo). 2011;66(1):73-6.

16.

Fallopian tube intraluminal tumor spread from noninvasive precursor lesions: a novel metastatic route in early pelvic carcinogenesis.

Bijron JG, Seldenrijk CA, Zweemer RP, Lange JG, Verheijen RH, van Diest PJ.

Am J Surg Pathol. 2013 Aug;37(8):1123-30. doi: 10.1097/PAS.0b013e318282da7f.

PMID:
23648462
17.

Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers.

Press JZ, Wurz K, Norquist BM, Lee MK, Pennil C, Garcia R, Welcsh P, Goff BA, Swisher EM.

Neoplasia. 2010 Dec;12(12):993-1002.

18.

Proliferation in the normal FTE is a hallmark of the follicular phase, not BRCA mutation status.

George SH, Milea A, Shaw PA.

Clin Cancer Res. 2012 Nov 15;18(22):6199-207. doi: 10.1158/1078-0432.CCR-12-2155. Epub 2012 Sep 11.

19.

BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype?

Cass I, Holschneider C, Datta N, Barbuto D, Walts AE, Karlan BY.

Obstet Gynecol. 2005 Dec;106(6):1327-34.

PMID:
16319259
20.

Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.

Vang R, Shih IeM, Kurman RJ.

Histopathology. 2013 Jan;62(1):44-58. doi: 10.1111/his.12046. Review.

PMID:
23240669

Supplemental Content

Support Center